BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) held its annual meeting of stockholders today in Indianapolis, IN. At the meeting, the Company’s stockholders voted to approve several key issues proposed by Enzon, including:
